Pharmacotherapy: A Pathophysiologic Approach
Description:
* Comprehensive: acclaimed in a prior edition as “the best pharmacotherapy textbook available,”* it offers you the most detailed pathophysiologic approach to selecting and using pharmaceutical agents in disease management and pharmaceutical care
* Current: the 5th Edition presents the latest information on new drugs and new approaches to treatment and disease management in all therapy sections
* New Chapters: now covers evidence-based medicine, pharmacogenetics, benign prostatic hyperplasia, endometriosis, erectile dysfunction, urinary incontinence, and much more
* Disease Management Focus: meets the needs of pharmacy curriculum and establishes a strong pathophysiologic basis for treatment
* Student-Friendly: provides clear explanations on how a particular organ system and related drug therapy is evaluated; includes dozens of treatment algorithms, figures and tables for quick readability; also offers the necessary background to understand topics including pharmacoeconomics and the used of evidence-based decision-making in practice
*Annals of Pharmacotherapy on the 4th Edition
Best prices to buy, sell, or rent ISBN 9780071212649
Frequently Asked Questions about Pharmacotherapy: A Pathophysiologic Approach
You can buy the Pharmacotherapy: A Pathophysiologic Approach book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $78.99 on Amazon and is available from 3 sellers at the moment.
If you’re interested in selling back the Pharmacotherapy: A Pathophysiologic Approach book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Pharmacotherapy: A Pathophysiologic Approach book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.